NCT03537404 - A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

June 24, 2017

Study Completion Date

June 30, 2017

Conditions

Healthy

Interventions

DRUG

Narlaprevir

100 mg, film-coated tablets, taken as 200 mg per os daily

DRUG

Ritonavir

100 mg, film-coated tablets, taken as 100 mg per os daily

DRUG

Tenofovir Disoproxil Fumarate

300 mg, film-coated tablets, taken as 300 mg per os daily

DRUG

Raltegravir

400 mg, film-coated tablets, taken as 400 mg per os daily

Trial Locations (1)

"Clinic Bessalar JSC", Moscow